Skip to main
MEDP
MEDP logo

Medpace Holdings (MEDP) Stock Forecast & Price Target

Medpace Holdings (MEDP) Analyst Ratings

Based on 10 analyst ratings
Hold
Strong Buy 0%
Buy 10%
Hold 60%
Sell 10%
Strong Sell 20%

Bulls say

Medpace Holdings is anticipating a 200-300 basis points increase in passthrough revenues in the second half of the year, building on elevated levels experienced in the second quarter. The company reported robust first-quarter results, highlighted by higher request for proposal (RFP) volumes, which supports its optimistic outlook on business growth. Additionally, Medpace expects its book-to-bill ratio to exceed 1.15x in the third quarter, indicating strong demand and potential for continued revenue expansion.

Bears say

Medpace Holdings has experienced an increase in backlog cancellations, which have been at or above what it considers the normal range, although these cancellations dropped to the lower end of expectations in Q2. The company has indicated uncertainty regarding the growth prospects of Direct Service revenue and does not anticipate a significant decline in 2026, which may imply cautious management of future revenue expectations. Furthermore, updated adjusted EBITDA estimates for 2025 and 2026 suggest a limited increase, driven by ongoing hiring in direct service costs and a decline in passthrough revenue, reflecting potential cost pressures that may affect profitability.

Medpace Holdings (MEDP) has been analyzed by 10 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 10% recommend Buy, 60% suggest Holding, 10% advise Selling, and 20% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medpace Holdings (MEDP) Forecast

Analysts have given Medpace Holdings (MEDP) a Hold based on their latest research and market trends.

According to 10 analysts, Medpace Holdings (MEDP) has a Hold consensus rating as of Oct 17, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $421.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $421.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medpace Holdings (MEDP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.